All four are in order, fastest above slowest — every timeframe pointing the same way.
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Prices this stock has turned at three or more times in the last 120 sessions, with how many times. Where buyers and sellers showed up before, not a forecast, an entry or a stop.
The base has run 4.0 weeks and fell 7% from its ceiling at its deepest. The pivot is $19.10, and the stock closed 13.0% above that pivot. Its relative strength rating is 89.
Read against an equal-weighted index of Pharmaceutical Preparations, which is +10.9% against the S&P 500 over six months Partly aligned.
- Earningstentativein 73dQuarterly earningsJan 28, 2027
No past reports on record for this company yet.
No figures in US GAAP filings for this company. Most foreign listings report under international standards, which this does not read.
Held by 1 of 46 tracked funds at the end of Q3 2026.
Last quarter: 1 bought new.
Checking your subscription…
From 13F filings, which show long stock only and arrive up to 45 days after the quarter. The broad quant funds are left out.
Nothing flagged for this company on the last market sweep.
Headlines link to the publisher. We do not host, summarise or rank them, and a headline appearing here is not a view about the company.
Sold: Platford Giles Richard, Bitetti Teresa Marie, Duprey Lauren Rusckowski, Plump Andrew Stewart, Greenway Nicola Deidre Petal, Shannon Elaine Mary, Farajallah Awny Samaan Botros, Ibrahim Ramy Riad Ahmed, Pacheco Rhonda Janice, Pignagnoli Agosti Marcello, Ricci Gabriele, Kim Julie So-Young, Furney Natalie Anne Marie.
Not counted above: 25 filings for awards, option exercises, gifts or shares withheld to pay tax. Those follow a vesting schedule nobody chose the timing of, and counting them as selling is how that number gets misread.
From SEC Form 4, filed within two business days of the trade. What was filed, not what it means.
6 of 9 published checks currently line up. This is a count, not a probability — nothing on this site measures how often a setup works.
These are analysts’ estimates, not ours, and not a projection this site endorses. They are published here because what the sell side expects is itself a fact about the market.
Checking your subscription…
Checking your subscription…
The most recent of 4 completed bases.
Checking your subscription…